Published in Proc Natl Acad Sci U S A on January 01, 1989
The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine. Genome Res (2009) 6.83
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest (2003) 4.42
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. Nature (2014) 3.29
Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology? Hum Genet (2007) 3.13
Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. Am J Hum Genet (1993) 2.46
Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia. Hum Mol Genet (2010) 2.19
A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res (1999) 2.13
RNase T1 mediated base-specific cleavage and MALDI-TOF MS for high-throughput comparative sequence analysis. Nucleic Acids Res (2003) 1.99
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet (2012) 1.96
High-resolution analysis of a hypervariable region in the human apolipoprotein B gene. Am J Hum Genet (1989) 1.91
Genetics of human cardiovascular disease. Cell (2012) 1.90
Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detection. Nucleic Acids Res (1993) 1.85
Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J Clin Invest (1993) 1.69
Familial defective apolipoprotein B-100 and increased low-density lipoprotein cholesterol and coronary artery calcification in the old order amish. Arch Intern Med (2010) 1.64
apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes. J Clin Invest (1995) 1.22
Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest (1995) 1.17
Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B. Am J Pathol (1991) 1.11
Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1. Proc Natl Acad Sci U S A (2011) 1.09
Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J Clin Invest (1990) 1.08
Familial hypercholesterolemia: the lipids or the genes? Nutr Metab (Lond) (2011) 1.04
Utility of genetic determinants of lipids and cardiovascular events in assessing risk. Nat Rev Cardiol (2011) 1.04
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk. J Lipid Res (2011) 0.96
Molecular spectrum of autosomal dominant hypercholesterolemia in France. Hum Mutat (2010) 0.95
Randomised by (your) god: robust inference from an observational study design. J Epidemiol Community Health (2006) 0.93
Basic concepts and potential applications of genetics and genomics for cardiovascular and stroke clinicians: a scientific statement from the American Heart Association. Circ Cardiovasc Genet (2015) 0.93
Diagnosis and treatment of apolipoprotein B dyslipoproteinemias. Nat Rev Endocrinol (2010) 0.93
Genetic basis of lipoprotein disorders. J Clin Invest (1989) 0.93
Apolipoprotein E competitively inhibits receptor-dependent low density lipoprotein uptake by the liver but has no effect on cholesterol absorption or synthesis in the mouse. Proc Natl Acad Sci U S A (1995) 0.91
LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives. Int Arch Med (2010) 0.91
A fourth locus for autosomal dominant hypercholesterolemia maps at 16q22.1. Eur J Hum Genet (2010) 0.91
Common and rare gene variants affecting plasma LDL cholesterol. Clin Biochem Rev (2008) 0.89
Polymorphic haplotypes and recombination rates at the LDL receptor gene locus in subjects with and without familial hypercholesterolemia who are from different populations. Am J Hum Genet (1993) 0.88
Why are low-density lipoproteins atherogenic? West J Med (1994) 0.88
The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles. J Lipid Res (2012) 0.87
Approach to identification of a point mutation in apo B100 gene by means of a PCR-mediated site-directed mutagenesis. Nucleic Acids Res (1991) 0.86
Identification and biochemical analysis of a novel APOB mutation that causes autosomal dominant hypercholesterolemia. Mol Genet Genomic Med (2013) 0.85
Dissecting the genetic contribution to coronary heart disease. Am J Hum Genet (1991) 0.85
Subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treated. PLoS One (2011) 0.84
Haplotype analysis of the human apolipoprotein B mutation associated with familial defective apolipoprotein B100. Am J Hum Genet (1990) 0.83
Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia. Core Evid (2012) 0.82
Cardiovascular risk assessment of dyslipidemic children: analysis of biomarkers to identify monogenic dyslipidemia. J Lipid Res (2014) 0.82
Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia. Vasc Health Risk Manag (2012) 0.82
Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis. Circ Res (2016) 0.81
Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children. Am J Hum Genet (1990) 0.80
Pedigree and sib-pair linkage analysis suggest the apolipoprotein B gene is not the major gene influencing plasma apolipoprotein B levels. Am J Hum Genet (1992) 0.79
Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia. J Med Genet (2000) 0.79
Genetic variation and atherosclerosis. Curr Genomics (2008) 0.79
A clinical approach to inherited premature coronary artery disease. Circ Cardiovasc Genet (2014) 0.79
Screening for mutations in exon 4 of the LDL receptor gene: identification of a new deletion mutation. J Med Genet (1995) 0.79
Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor. J Clin Invest (1993) 0.79
Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction. Eur J Hum Genet (2015) 0.78
Genomic Study of Cardiovascular Continuum Comorbidity. Acta Naturae (2015) 0.78
Genomic characterization of large rearrangements of the LDLR gene in Czech patients with familial hypercholesterolemia. BMC Med Genet (2010) 0.78
Variable expressivity and co-occurrence of LDLR and LDLRAP1 mutations in familial hypercholesterolemia: failure of the dominant and recessive dichotomy. Mol Genet Genomic Med (2016) 0.77
Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population. BMC Med Genet (2015) 0.77
Apolipoproteins and metabolism in atherosclerosis. Trans Am Clin Climatol Assoc (1990) 0.77
Molecular characterization of Iranian patients with possible familial hypercholesterolemia. Indian J Clin Biochem (2011) 0.77
Hypercholesterolemia and Dyslipidemia. Curr Treat Options Cardiovasc Med (2000) 0.77
The genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations. Appl Clin Genet (2010) 0.77
Anderson's disease: genetic exclusion of the apolipoprotein-B gene in two families. J Clin Invest (1991) 0.76
Mutations in the low-density-lipoprotein receptor gene in German patients with familial hypercholesterolaemia. J Inherit Metab Dis (2000) 0.76
Association between CETP, MLXIPL, and TOMM40 polymorphisms and serum lipid levels in a Latvian population. Meta Gene (2014) 0.76
Genetic screening for homozygous and heterozygous familial hypercholesterolemia. Appl Clin Genet (2010) 0.76
Genetics of coronary artery disease: discovery, biology and clinical translation. Nat Rev Genet (2017) 0.76
Clinical utility gene card for: hyperlipoproteinemia, TYPE II. Eur J Hum Genet (2013) 0.76
Absence of Apo B R3500Q Mutation among Kelantanese Malays with Hyperlipidaemia. Malays J Med Sci (2000) 0.75
Six DNA polymorphisms in the low density lipoprotein receptor gene: their genetic relationship and an example of their use for identifying affected relatives of patients with familial hypercholesterolaemia. J Med Genet (1993) 0.75
Targeted exonic sequencing of GWAS loci in the high extremes of the plasma lipids distribution. Atherosclerosis (2016) 0.75
The real code of leonardo da vinci. Curr Cardiol Rev (2008) 0.75
Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives. Acta Pharmacol Sin (2017) 0.75
Genetics of coronary artery disease and myocardial infarction. World J Cardiol (2016) 0.75
Using new tools to define the genetic underpinnings of risky traits associated with coronary artery disease: the SardiNIA study. Trends Cardiovasc Med (2009) 0.75
Autosomal dominant hypercholesterolemia: needs for early diagnosis and cascade screening in the tunisian population. Curr Genomics (2013) 0.75
Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred. Eur J Epidemiol (1992) 0.75
Characterization of a family with moderate hypercholesterolemia and binding defective low density lipoprotein. Eur J Epidemiol (1992) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
Molecular basis of base substitution hotspots in Escherichia coli. Nature (1978) 13.79
Globin mRNA sequences: analysis of base pairing and evolutionary implications. Cold Spring Harb Symp Quant Biol (1978) 13.15
DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res (1980) 9.34
Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. Cell (1984) 8.14
Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature (1986) 2.12
Nonsense and missense mutations in hemophilia A: estimate of the relative mutation rate at CG dinucleotides. Am J Hum Genet (1988) 1.93
Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci U S A (1987) 1.93
DNA sequence of the human apolipoprotein B gene. DNA (1987) 1.88
Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction. N Engl J Med (1986) 1.55
The complete sequence and structural analysis of human apolipoprotein B-100: relationship between apoB-100 and apoB-48 forms. EMBO J (1986) 1.49
Analysis of cDNA clones encoding the entire B-26 region of human apolipoprotein B. Proc Natl Acad Sci U S A (1986) 1.48
Mapping of antigenic determinants of human apolipoprotein B using monoclonal antibodies against low density lipoproteins. J Biol Chem (1982) 1.47
Human liver apolipoprotein B-100 cDNA: complete nucleic acid and derived amino acid sequence. Proc Natl Acad Sci U S A (1986) 1.42
Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet (1986) 1.41
The complete cDNA and amino acid sequence of human apolipoprotein B-100. J Biol Chem (1986) 1.39
Genetic factors affecting blood lipoproteins: the candidate gene approach. J Lipid Res (1988) 1.38
In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia. J Clin Invest (1986) 1.37
Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hyperlipidaemic individuals. Atherosclerosis (1987) 1.32
Molecular weights of apoprotein B obtained from human low-density lipoprotein (apoprotein B-PI) and from rat very low density lipoprotein (apoprotein B-PIII). Biochemistry (1985) 1.26
DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level. Clin Genet (1986) 1.20
Genetic linkage between the antigenic group (Ag) variation and the apolipoprotein B gene: assignment of the Ag locus. Proc Natl Acad Sci U S A (1986) 1.12
Mapping of human apolipoprotein B antigenic determinants. Arteriosclerosis (1987) 1.07
Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48. J Biol Chem (1984) 1.05
Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins. Proc Natl Acad Sci U S A (1988) 0.98
Analysis of the human apolipoprotein B gene; complete structure of the B-74 region. Gene (1986) 0.96
Genetic variation in serum low density lipoproteins and lipid levels in man. Proc Natl Acad Sci U S A (1976) 0.92
ApoB gene MspI RFLP in exon 26 changes amino acid 3611 from Arg to Gln. J Lipid Res (1988) 0.89
Ag system re-explored: studies with monoclonal anti-apolipoprotein B antibodies. Adv Exp Med Biol (1987) 0.83
DNA sequence analysis of the transposon Tn3: three genes and three sites involved in transposition of Tn3. Cell (1979) 13.52
Specificity of substrate recognition by the EcoRI restriction endonuclease. Proc Natl Acad Sci U S A (1975) 11.07
Nucleic acid reassociation in formamide. Biochemistry (1969) 8.77
Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1999) 8.04
Rate of fixation of nucleotide substitutions in evolution. Nature (1969) 6.57
Sequence of three copies of the gene for the major Drosophila heat shock induced protein and their flanking regions. Cell (1980) 6.17
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation (1999) 5.62
Nucleotide sequence of the bacterial transposon Tn1681 encoding a heat-stable (ST) toxin and its identification in enterotoxigenic Escherichia coli strains. Proc Natl Acad Sci U S A (1980) 5.46
In vitro mutagenesis of a circular DNA molecule by using synthetic restriction sites. Proc Natl Acad Sci U S A (1978) 5.32
The underregistration of neonatal deaths: Georgia 1974--77. Am J Public Health (1980) 4.82
The E. coli gene encoding heat stable toxin is a bacterial transposon flanked by inverted repeats of IS1. Nature (1979) 3.94
Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest (1995) 3.44
Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus. JAMA (1994) 3.30
Sequence organization of two recombinant plasmids containing genes for the major heat shock-induced protein of D. melanogaster. Cell (1979) 3.21
Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation (1998) 3.18
The Synthesis of Ribosomes in E. coli: I. The Incorporation of C-Uracil into the Metabolic Pool and RNA. Biophys J (1962) 3.16
Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med (2000) 3.14
The Synthesis of Ribosomes in E. coli: III. Synthesis of Ribosomal RNA. Biophys J (1962) 3.14
DNA sequence of a plasmid-encoded dihydrofolate reductase. Mol Gen Genet (1981) 2.98
Cholesterol and coronary heart disease. A new era. JAMA (1986) 2.95
Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation (2001) 2.93
Risk factors for the development of cholelithiasis in man (second of two parts). N Engl J Med (1978) 2.78
Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia. J Clin Invest (1975) 2.65
Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation (2001) 2.60
A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A (1997) 2.53
Comparative study of ribosomal ribonucleic acid cistrons in enterobacteria and myxobacteria. J Bacteriol (1967) 2.51
Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med (1984) 2.44
Should a low-fat, high-carbohydrate diet be recommended for everyone? Beyond low-fat diets. N Engl J Med (1997) 2.43
Related base sequences in the DNA of simple and complex organisms. I. DNA-DNA duplex formation and the incidence of partially related base sequences in DNA. Biochem Genet (1968) 2.39
Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels. N Engl J Med (1988) 2.37
Evidence for ribonucleic acid molecules restricted to the cell nucleus. Biochemistry (1967) 2.35
Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men. Arch Intern Med (1993) 2.32
Hypercholesterolemia in elderly persons: resolving the treatment dilemma. Ann Intern Med (1990) 2.28
Characterization of the deoxyribonucleic acid of various strains of halophilic bacteria. J Bacteriol (1969) 2.27
Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol (1999) 2.27
Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab (1999) 2.25
A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest (1997) 2.23
Rationale of the diet-heart statement of the American Heart Association. Report of Nutrition Committee. Circulation (1982) 2.21
The rate of change of DNA in evolution. Brookhaven Symp Biol (1972) 2.21
Effects of obesity and caloric intake on biliary lipid metabolism in man. J Clin Invest (1975) 2.17
AHA Conference Proceedings. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: executive summary. American Heart Association. Circulation (2000) 2.16
Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. J Lab Clin Med (1971) 2.15
Metabolism of beta-sitosterol in man. J Clin Invest (1970) 2.15
The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data. Cancer (1999) 2.12
Magnitude of interspecific nucleotide sequence variability in Drosophila. Genetics (1968) 2.12
Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers. J Lipid Res (1994) 2.11
Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res (1985) 2.11
Measurements of cholesterol turnover, synthesis, and absorption in man, carried out by isotope kinetic and sterol balance methods. J Lipid Res (1969) 2.09
Regulation of Drosophila alpha- and beta-tubulin genes during development. Dev Biol (1984) 2.07
Mechanisms of lithogenic bile formation in American Indian women with cholesterol gallstones. J Clin Invest (1972) 2.01
Hybridization of ribonucleic acid with unique sequences of mouse deoxyribonucleic acid. Biochemistry (1972) 1.98
Systemically wound-responsive genes in poplar trees encode proteins similar to sweet potato sporamins and legume Kunitz trypsin inhibitors. Plant Mol Biol (1990) 1.98
Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci U S A (1979) 1.96
Risk factors for the development of cholelithiasis in man (first of two parts). N Engl J Med (1978) 1.94
Changing populations of messenger RNA during sea urchin development. Proc Natl Acad Sci U S A (1966) 1.93
Complexity of cytoplasmic RNA in different mouse tissues measured by hybridization of polyadenylated RNA to complementary DNA. Biochemistry (1975) 1.93
Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci U S A (1987) 1.93
AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol (1999) 1.92
Ad libitum oral glucose-electrolyte therapy for acute diarrhea in Apache children. J Pediatr (1973) 1.92
High-resolution analysis of a hypervariable region in the human apolipoprotein B gene. Am J Hum Genet (1989) 1.91
Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res (1990) 1.90
Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Proc Natl Acad Sci U S A (1983) 1.89
Isolation and characterisation of an unusual collagen from hyaline cartilage and intervertebral disc. FEBS Lett (1981) 1.89
Base sequence homology and renaturation studies of the deoxyribonucleic acid of extremely halophilic bacteria. J Bacteriol (1969) 1.88
DNA sequence of the human apolipoprotein B gene. DNA (1987) 1.88
Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol (1993) 1.87
Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice. Am J Clin Nutr (1997) 1.86
Multiple actin-related sequences in the Drosophila melanogaster genome. Cell (1980) 1.86
The relationship between mismatched base pairs and the thermal stability of DNA duplexes. II. Effects of deamination of cytosine. Biochim Biophys Acta (1973) 1.85
Two Drosophila actin genes in detail. Gene structure, protein structure and transcription during development. J Mol Biol (1983) 1.85
The introduction of radioisotopes into RNA by methylation in vitro. Biochim Biophys Acta (1967) 1.84
Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo. J Clin Invest (1979) 1.82
Dietary beta-sitosterol as an internal standard to correct for cholesterol losses in sterol balance studies. J Lipid Res (1968) 1.76
Four Drosophila heat shock genes at 67B: characterization of recombinant plasmids. Nucleic Acids Res (1980) 1.76
Messenger RNA complexity in Drosophila melanogaster. Biochemistry (1975) 1.76
Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N Engl J Med (1986) 1.75
Hybridization of 125I-labeled ribonucleic acid. Biochemistry (1973) 1.74
A physiological method for estimation of hepatic secretion of biliary lipids in man. Gastroenterology (1972) 1.73
Molecular characterization of the Drosophila genome. Genetics (1969) 1.72
A dispersed multigene family encoding tubulin in Drosophila melanogaster. Cell (1980) 1.70
Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc Natl Acad Sci U S A (1998) 1.70
American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation (2000) 1.69
Complete cDNA and derived protein sequence of human apolipoprotein B-100. Nucleic Acids Res (1986) 1.68
Comparison of effects of lauric acid and palmitic acid on plasma lipids and lipoproteins. Am J Clin Nutr (1992) 1.67
Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. JAMA (1990) 1.65
Diurnal variation in biliary lipid composition. Possible role in cholesterol gallstone formation. N Engl J Med (1973) 1.64
American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol (2000) 1.64
Effects of diabetes mellitus on cholesterol metabolism in man. N Engl J Med (1977) 1.63
DNA Comparisons among Barley, Oats, Rye, and Wheat. Genetics (1970) 1.63
Ribonucleic acid synthesis in regenerating and embryonic liver. I. The synthesis of new species of RNA during regeneration of mouse liver after partial hepatectomy. J Mol Biol (1967) 1.61
Genetic and base sequence homologies in bacillus. Genetics (1969) 1.60
Statin trials and goals of cholesterol-lowering therapy. Circulation (1998) 1.60
Genes for three Drosophila heat-shock-induced proteins at a single locus. Proc Natl Acad Sci U S A (1980) 1.59
The interaction of oligodeoxynucleotides with denatured DNA. Biochim Biophys Acta (1967) 1.57
The interaction of cholesterol absorption and cholesterol synthesis in man. J Lipid Res (1969) 1.56